LANE HEDER: Open Payments
NPI 1083641286 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 39 payments from 15 companies in 2025. Trend: 2023 $987 · 2024 $529 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $219 |
| PFIZER INC. | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Lundbeck LLC | 2 | $49 |
| Abbott Laboratories | 2 | $34 |
| Lilly USA, LLC | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| Axsome Therapeutics, Inc. | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, QULIPTA, REXULTI, NURTEC ODT, FREESTYLE LIBRE 3, TZIELD, LINZESS.
Industry payments across UT — which companies pay providers there.
